Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 4 1Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 31Neoplasms 6Breast Neoplasms 6Prostatic Neoplasms, Castration-Resistant 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Metastatic Castration Resistant Prostate Cancer 4Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Prostate Adenocarcinoma 2Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Ureteral Diseases 1Thrombocytosis 1Solid Tumours 1Solid Tumor 1Small Cell Lung Carcinoma 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pharmacokinetics of MDV3100 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1

Interventions

enzalutamide 4rucaparib 1abiraterone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Metastatic Castration Resistant Prostate Cancer × enzalutamide × Clear all
NCT03776968 2024-10-23

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

Hinova Pharmaceuticals Inc.

Phase 1 Completed
47 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

NCT04179396 2023-06-29

RAMP

pharmaand GmbH

Phase 1 Completed
8 enrolled 8 charts
Genitourinary

Metastatic Castration Resistant Prostate Cancer

NCT03774056 2020-11-03

A Study Evaluating Tolerability, Pharmacokinetics, and Preliminary Efficacy of HC-1119 in Patients.

Hinova Pharmaceuticals Inc.

Phase 1 Completed
43 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

NCT03778047 2020-11-03

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

Hinova Pharmaceuticals Inc.

Phase 1 Completed
10 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡